Olema Pharmaceuticals OLMA 深 沪
交易中 11-11 11:02:05 美东时间
7.16
-0.110
-1.51%
华盛通- 最 高7.328
- 今 开7.29
- 成交量 8.95万股
- 最 低 7.07
- 昨 收 7.27
- 总市值 6.26亿
- 52周最高 36.2591
- 市盈率 静 --
- 换手率 0.10%
- 52周最低 6.235
- 委 比 -30.72%
- 总股本 8749.76万
- 历史最高 60.27
- 量 比 0.35
- 振 幅 3.55%
- 历史最低 2.00
- 每 手 1
- 风险率 7.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Olema Pharmaceuticals Q3 EPS $(0.73) Misses $(0.63) Estimate
Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.63) by 17.74 percent. This is a 48.98 percent decrease over losses of $(0.49) per share from the same period last year.
11-10 20:24
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Olema Pharmaceuticals granted stock options to 10 new employees for 261,300 shares, effective November 2, 2026. The options vest over four years, with 25% vesting after the first year and the remainder in monthly installments over the next three years. The exercise price is $7.07 per share, matching the closing price on November 2, 2026. The awards were approved by the Compensation Committee under the 2022 Inducement Plan, in compliance with Nasd...
11-03 21:30
Olema Oncology to Participate in Upcoming Investor Conferences
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on targeted therapies for breast cancer, announced its participation in four upcoming investor conferences in November 2026. The events include the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston, the Stifel 2026 Healthcare Conference in New York, and the UBS Global Biopharma and Jefferies Global Healthcare Conferences in London. Each session will fea...
11-02 21:30
Olema Pharmaceuticals Updates Board Committees Following Resignation
Olema Pharmaceuticals ( ($OLMA) ) has shared an update. On October 12, 2026, Ol...
10-16 05:29
美股大行评级 | 机构看淡消费股！麦当劳、耐克、卡夫亨氏齐遭降目标价；能源股获齐声唱多
今日重点评级关注：Ascendiant Capital：维持SurgePays"买入"评级，目标价从3.5美元升至3.75美元；HC Wainwright & Co.：维持Spero Therapeutics"买入"评级，目标价从5美元升至6美元
09-15 15:30
Stifel Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $30
Stifel analyst Laura Prendergast maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from $48 to $30.
09-15 02:03
Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq 100 futures falling around 500 points on Monday. Shares of Corning Inc (NYSE:GLW) fell sharply in pre-market trading after the company announced a $2 billion offering. Corning shares dipped 8% to $153.05 in pre-market trading. Here are some...
09-14 20:02
Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of Scholar Rock Holding Corp (NASDAQ:SRRK) rose sharply in pre-market trading after the company announced the FDA approval of ISEMBYLD (apitegromab-mstn), the first and only muscle-targeted treatment for children and adults with Spinal Muscular Atrophy (SMA). Scholar Rock Holding shares jumpe...
09-14 17:50
Olema drops after hours on AstraZeneca Etcamah data
Olema Pharmaceuticals (OLMA), which is developing the estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) palazestrant, is down ~15% in after-hours trading Friday afte...
09-12 06:32
Olema Oncology names Jason O’Byrne as CFO
Olema Pharmaceuticals (OLMA) has appointed Jason O’Byrne as chief financial officer. O’Byrne brings more than two decades of finance and global operations leadership across high-growth biotechnology a...
08-13 21:25
